Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New cardiovascular drugs reported by Yamanouchi

July 17, 1997

Kanebo reports novel cell adhesion inhibitors

July 17, 1997

Dual mechanism of action for antiatherosclerotic compound Org-13061

July 16, 1997

Eclipse submits PMA for Transmyocardial Revascularization procedure

July 15, 1997

Potent and selective M2 receptor antagonist discovered by Yamanouchi

July 15, 1997

Mibefradil more effective than extended-release diltiazem in hypertension

July 15, 1997

MMP inhibitors from Warner-Lambert

July 15, 1997

Rutaecarpine, a vasorelaxant component of an herbal drug

July 15, 1997

More on aspirin in cardiovascular medicine

July 14, 1997

Knoll receives FDA approval to market Mavik for new indication

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...